sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Europe Rare Neurological Disease Treatment Market Scope And Analysis

  • Report Code : TIPRE00010244
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 154
Buy Now

Europe Rare Neurological Disease Treatment Market Scope and Key Players Analysis by 2027

Buy Now

Europe Rare Neurological Disease Treatment Market Report Europe Rare Neurological Disease Treatment Market Size and Share Europe Rare Neurological Disease Treatment Market Scope and Analysis

Europe Rare Neurological Disease Treatment Market Report Scope

Report Attribute Details
Market size in 2019 US$ 2,048.10 Million
Market Size by 2027 US$ 3,763.41 Million
Global CAGR (2019 - 2027) 8.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Indication
  • Narcolepsy
  • Amyotrophic Lateral Sclerosis
  • Alzheimer
By Drug Type
  • Organic Compounds
  • Biologics
By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
By Mode of Administration
  • Oral
  • Injectables
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Allergan plc
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson Johnson Services Inc
  • Merck Co Inc
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd